4 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 4 |
Follow Urinary Bladder Cancer: new trials by email Literature Review of Urinary Bladder Cancer trials Research Report on Urinary Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma Sequential Gemcitabine and Jelmyto Treatment (Gem/Jel) - Urinary Bladder Cancer, Upper Tract Urothelial Cancer | Phase 2 | Recruiting | Rutgers, The State University of New Jersey | 28 | 2026-03-06 | 2026-05-06 |
| Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial Riluzole, Placebo - Breast Cancer, Sarcoma | Phase 2 | Recruiting | University of California, Irvine | 75 | 2024-12-02 | 2026-07-14 |
| Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer Pembrolizumab - Bladder Cancer, Bladder Neoplasms | Phase 2 | Recruiting | Peking University First Hospital | 54 | 2021-12-07 | 2022-01-10 |
| Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin - Urinary Bladder Cancer | Phase 2 | Recruiting | Zhujiang Hospital | 41 | 2021-06-03 | 2026-10-09 |
Urinary Bladder Neoplasms (4) · Brain Neoplasms (1) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Head and Neck Neoplasms (1) · Hodgkin Disease (1) · Kidney Neoplasms (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Melanoma (1) · Multiple Myeloma (1) · Mycosis Fungoides (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Urinary Bladder Diseases (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Urologic Neoplasms (4) · Urogenital Neoplasms (3) · Adnexal Diseases (1) · Blood Protein Disorders (1) · Brain Diseases (1) · Breast Diseases (1) · Cardiovascular Diseases (1)
Gemcitabine (2) · Cisplatin (1) · Immune Checkpoint Inhibitors (1) · Riluzole (1) · pembrolizumab (1) · toripalimab (1)
Peking University First Hospital (1) · Rutgers, The State University of New Jersey (1) · University of California, Irvine (1) · Zhujiang Hospital (1)
China (2) · United States (2)
Abai Xu, doctor (1) · Alexandre Chan, PharmD, MPH (1) · Zhi-Song He, MD (1)